Cargando…
Application of microfluidic technologies on COVID-19 diagnosis and drug discovery
The ongoing coronavirus disease 2019 (COVID-19) pandemic has boosted the development of antiviral research. Microfluidic technologies offer powerful platforms for diagnosis and drug discovery for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis and drug discovery. In this revie...
Autores principales: | Lin, Zhun, Zou, Zhengyu, Pu, Zhe, Wu, Minhao, Zhang, Yuanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951611/ https://www.ncbi.nlm.nih.gov/pubmed/36855672 http://dx.doi.org/10.1016/j.apsb.2023.02.014 |
Ejemplares similares
-
Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients
por: Zou, Zhengyu, et al.
Publicado: (2023) -
Nanomaterial-based Microfluidic Chips for the Capture and Detection of Circulating Tumor Cells
por: Sun, Duanping, et al.
Publicado: (2017) -
Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients
por: Wei, Liwen, et al.
Publicado: (2021) -
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
por: Rezaei Kolahchi, Ahmad, et al.
Publicado: (2016) -
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
por: Fu, Jingyu, et al.
Publicado: (2023)